Literature DB >> 9079396

Involvement of programmed cell death in preimplantation embryo demise.

A Jurisicova1, S Varmuza, R F Casper.   

Abstract

Fragmentation is frequently observed in animal and human embryos obtained via in-vitro fertilization (IVF), and is known to be associated with decreased pregnancy rates and poor survival following cryopreservation. We postulate that embryo fragmentation is a consequence of activated programmed cell death (PCD) and subsequent apoptosis and discuss evidence of morphological, histological and biochemical features compatible with the occurrence of PCD in preimplantation embryos. If PCD is an underlying cause of the high incidence of the fragmentation seen in human pre-embryos, it remains to be determined whether this is reflective of the natural incidence of lethal chromosomes in the human population or due to the IVF procedure and culture conditions.

Entities:  

Mesh:

Year:  1995        PMID: 9079396     DOI: 10.1093/humupd/1.6.558

Source DB:  PubMed          Journal:  Hum Reprod Update        ISSN: 1355-4786            Impact factor:   15.610


  4 in total

1.  Cryopreservation: An emerging paradigm change.

Authors:  John G Baust; Dayong Gao; John M Baust
Journal:  Organogenesis       Date:  2009-07       Impact factor: 2.500

2.  Role of autocrine mediators in the regulation of embryo viability: lessons from animal models.

Authors:  C O'Neill
Journal:  J Assist Reprod Genet       Date:  1998-09       Impact factor: 3.412

3.  Hybrid vigor and transgenerational epigenetic effects on early mouse embryo phenotype.

Authors:  Zhiming Han; Namdori R Mtango; Bela G Patel; Carmen Sapienza; Keith E Latham
Journal:  Biol Reprod       Date:  2008-06-18       Impact factor: 4.285

4.  Early transcription from the maternal genome controlling blastomere integrity in mouse two-cell-stage embryos.

Authors:  Zhiming Han; Namdori R Mtango; Zhisheng Zhong; Rita Vassena; Keith E Latham
Journal:  Am J Physiol Cell Physiol       Date:  2010-01-27       Impact factor: 4.249

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.